Advertisement

Topics

Avalon Pharmaceuticals Company Profile

03:50 EDT 22nd June 2018 | BioPortfolio

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon is able to pinpoint proprietary drug activity markers and drug targets and to use these for drug screening in complex biological systems, facilitating the identification of lead drug candidates. Avalon is developing these drug candidates both internally and through partnerships within the pharmaceutical industry.

By attracting a leading team of innovative scientists and drug discovery experts, utilizing cutting-edge genomics tools, and forming strategic alliances within the industry, Avalon is significantly decreasing the time it takes to develop novel drug therapies to treat deseases. Within the Company's first two-years, Avalon scientists were able to use their novel genomic discovery and screening approaches to identify several small molecule drug candidates for the treatment of cancer.



Avalon identifies small molecule therapeutic compounds directly from genomics data in three steps:



Identification of novel and key proprietary drug activity markers using a comprehensive set of genomics tools including molecular and pathological characterization, cytogenetics, and high density gene expression arrays,

Screening for new small molecule therapeutic compounds using its proprietary methods such as the Company's multi-parameter assays, and

Optimization of lead compounds using cutting-edge medicinal chemistry.

The company's initial therapeutic focus area is solid tumors including cancers of colon, breast, lung, and prostate.



Avalon's strategy of combining the latest genomic approaches for gene and target identification with an aggressive pursuit of small molecule drug discovery has attracted significant interest from the pharmaceutical industry. In order to quickly pursue large-scale discovery and drug development within particular disease areas, Avalon enters partnerships with pharmaceutical companies as well as collaborative agreements with clinical and academic institutions.

Location

20358 Seneca Meadows Parkway
Germantown
20876
United States of America

Contact

Phone: 301-556-1000
Fax: 301-556-1100
Email: info@avalonrx.com


News Articles [502 Associated News Articles listed on BioPortfolio]

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. ...

FREEHOLD, NJ--(Marketwired - January 21, 2018) -Avalon GloboCare Corp. ( OTCQB : AVCO), a leading global developer of cell-based technologies, announced today Read more...

GSK & Avalon Ventures: Collaborating to invest $495 million in early stage life science companies

In this episode of PharmaTelevision News Review, filmed at Bio Conference 2013, in Chicago, USA, Fintan Walton talks to Jay Lichter of Avalon Ventures & Lon Cardon of GSK.

2019 Toyota Avalon Promises to Be a Functional Family-Friendly Cruiser

Avalon GloboCare Submits Listing Application for The NASDAQ Capital Market

FREEHOLD, NJ--(Marketwired - March 19, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today it has filed an application for listing on t...

Avalon GloboCare Appoints Former Deputy Secretary of the U.S. Department of Health and Human Services Dr. Tevi Troy to its Board of Directors

FREEHOLD, N.J, June 04, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Dr. Tevi ...

Avalon GloboCare Forms Joint Laboratory with Top-Ranked Hospital in Shanghai for Regenerative Exosomics

FREEHOLD, NJ--(Marketwired - April 24, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company's subsidiary, GenExosome T...

Avalon GloboCare Provides First Quarter 2018 Business Update; Reports 365% Increase in Revenues and Progress Towards Commercialization of its Cell-Based Technologies

FREEHOLD, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a busines...

Avalon GloboCare Forms Joint Venture with Jiangsu Unicorn to Establish Provincial Network of Translational Cellular Therapy and Bio-Banking Programs

FREEHOLD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has formed a joint ve...

PubMed Articles [137 Associated PubMed Articles listed on BioPortfolio]

Elective Intraoperative Use of an Avalon Elite Catheter During Lung Transplantation.

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [217 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1325 Associated Companies listed on BioPortfolio]

Avalon Pharmaceuticals

Avalon Pharmaceuticals' primary mission is to discover and develop innovative small molecule therapeutics using cutting-edge genomic technologies. Through its comprehensive genomics approach, Avalon i...

Avalon Instruments

The Avalon's range of Raman Analyzers offer you High Performance Raman Spectoscopy. Our cutting edge detection, sampling technology, automated calibration and pinned-in-place optics coupled with our i...

Avalon Network NV

Avalon Network helps you to realise re-engineering benefits trough information technology. Our multi-level approach makes our projects Human-centered Result-oriented Technologically reliable We team u...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Avalon Pharmaceuticals" on BioPortfolio

We have published hundreds of Avalon Pharmaceuticals news stories on BioPortfolio along with dozens of Avalon Pharmaceuticals Clinical Trials and PubMed Articles about Avalon Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avalon Pharmaceuticals Companies in our database. You can also find out about relevant Avalon Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record